Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


11.03.2019

2 Acta Psychiatr Scand
4 Am J Psychiatry
2 Br J Psychiatry
1 Cereb Cortex
1 Compr Psychiatry
1 J Clin Psychiatry
1 J Clin Psychopharmacol
1 Neuropsychopharmacology
1 Neurosci Lett
1 PLoS Genet
1 PLoS One
4 Psychiatry Res
2 Psychol Med
4 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. GOHAR SM, Dieset I, Steen NE, Morch RH, et al
    Association between Leptin Levels and Severity of Suicidal Behaviour in Schizophrenia Spectrum Disorders.
    Acta Psychiatr Scand. 2019 Mar 8. doi: 10.1111/acps.13019.
    PubMed     Text format     Abstract available

  2. SHER L, Kahn RS
    Family interventions and prevention of suicide in first-episode schizophrenia.
    Acta Psychiatr Scand. 2019 Mar 6. doi: 10.1111/acps.13018.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  3. WEINBERGER DR
    Polygenic Risk Scores in Clinical Schizophrenia Research.
    Am J Psychiatry. 2019;176:3-4.
    PubMed     Text format    

  4. WEINBERGER DR
    Thinking About Schizophrenia in an Era of Genomic Medicine.
    Am J Psychiatry. 2019;176:12-20.
    PubMed     Text format     Abstract available

  5. BEST MW, Milanovic M, Iftene F, Bowie CR, et al
    A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning.
    Am J Psychiatry. 2019 Mar 8:appiajp201818070849.
    PubMed     Text format     Abstract available

  6. MARTIN WF, Correll CU, Weiden PJ, Jiang Y, et al
    Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
    Am J Psychiatry. 2019 Mar 8:appiajp201818030280.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  7. PRIEBE S, Chevalier A, Hamborg T, Golden E, et al
    Effectiveness of a volunteer befriending programme for patients with schizophrenia: randomised controlled trial.
    Br J Psychiatry. 2019 Mar 4:1-7. doi: 10.1192/bjp.2019.
    PubMed     Text format     Abstract available

  8. SOLMI F, Mascarell MC, Zammit S, Kirkbride JB, et al
    Polygenic risk for schizophrenia, disordered eating behaviours and body mass index in adolescents.
    Br J Psychiatry. 2019 Mar 6:1-6. doi: 10.1192/bjp.2019.
    PubMed     Text format     Abstract available


    Cereb Cortex

  9. MAKOWSKI C, Lewis JD, Lepage C, Malla AK, et al
    Structural Associations of Cortical Contrast and Thickness in First Episode Psychosis.
    Cereb Cortex. 2019 Mar 7. pii: 5371084. doi: 10.1093.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  10. KOTLICKA-ANTCZAK M, Karbownik MS, Pawelczyk A, Zurner N, et al
    A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state.
    Compr Psychiatry. 2019;90:95-101.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  11. KANE JM, Agid O, Baldwin ML, Howes O, et al
    Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  12. SAGLAM AYKUT D
    Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    J Clin Psychopharmacol. 2019;39:57-62.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  13. LEUCHT S, Barabassy A, Laszlovszky I, Szatmari B, et al
    Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.
    Neuropsychopharmacology. 2019 Mar 5. pii: 10.1038/s41386-019-0363.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. NATHOU C, Duprey E, Simon G, Razafimandimby A, et al
    Effects of low- and high-frequency repetitive transcranial magnetic stimulation on long-latency auditory evoked potentials.
    Neurosci Lett. 2018;686:198-204.
    PubMed     Text format     Abstract available


    PLoS Genet

  15. TOMA C, Pierce KD, Shaw AD, Heath A, et al
    Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.
    PLoS Genet. 2018;14:e1007535.
    PubMed     Text format     Abstract available


    PLoS One

  16. LEIGHTON SP, Krishnadas R, Chung K, Blair A, et al
    Predicting one-year outcome in first episode psychosis using machine learning.
    PLoS One. 2019;14:e0212846.
    PubMed     Text format     Abstract available


    Psychiatry Res

  17. MIKE L, Guimond S, Kelly S, Thermenos H, et al
    Social cognition in early course of schizophrenia: Exploratory factor analysis.
    Psychiatry Res. 2019;272:737-743.
    PubMed     Text format     Abstract available

  18. HUANG LJ, Hu FC, Wu C, Yang YH, et al
    Traditional-Chinese Dispositional Flow Scale-2 and Flow State Scale-2 in Taiwanese subjects with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2018;274:287-293.
    PubMed     Text format     Abstract available

  19. SI TM, Zhang YL, Feng Y, Zhuo JM, et al
    Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation.
    Psychiatry Res. 2019;274:301-305.
    PubMed     Text format     Abstract available

  20. BUCHMANN CB, Pedersen G, Aminoff SR, Laskemoen JF, et al
    Validity of the Birchwood insight scale in patients with schizophrenia spectrum- and bipolar disorders.
    Psychiatry Res. 2019;272:715-722.
    PubMed     Text format     Abstract available


    Psychol Med

  21. CARRA G, Crocamo C, Bartoli F, Angermeyer M, et al
    The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling.
    Psychol Med. 2019 Mar 8:1-9. doi: 10.1017/S0033291719000321.
    PubMed     Text format     Abstract available

  22. WEISER M, Fenchel D, Frenkel O, Fruchter E, et al
    Understanding the association between advanced paternal age and schizophrenia and bipolar disorder.
    Psychol Med. 2019 Mar 4:1-7. doi: 10.1017/S0033291719000242.
    PubMed     Text format     Abstract available


    Schizophr Res

  23. VALIENTE C, Espinosa R, Trucharte A, Nieto J, et al
    The challenge of well-being and quality of life: A meta-analysis of psychological interventions in schizophrenia.
    Schizophr Res. 2019 Mar 1. pii: S0920-9964(19)30043.
    PubMed     Text format    

  24. HALL MH, Holton KM, Ongur D, Montrose D, et al
    Longitudinal trajectory of early functional recovery in patients with first episode psychosis.
    Schizophr Res. 2019 Feb 27. pii: S0920-9964(19)30053.
    PubMed     Text format     Abstract available

  25. KALAYASIRI R, Kraijak K, Mutirangura A, Maes M, et al
    Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia.
    Schizophr Res. 2019 Feb 27. pii: S0920-9964(19)30075.
    PubMed     Text format     Abstract available

  26. CURTO M, Lionetto L, Fazio F, Corigliano V, et al
    Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Schizophr Res. 2019 Mar 2. pii: S0920-9964(19)30080.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: